The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse

International Urogynecology Journal

Volumn 22, Issue 6, 2011, Pages 705-712

  Skala, Christine Elisabeth ^a   Petry, Ilka Brigitte ^a   Albrich, Stefan ^a   Puhl, Alexander ^a   Naumann, Gert ^a   Koelbl, Heinz ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Estrogen receptor; Lower urinary tract symptoms; Overactive bladder symptoms; Pelvic organ prolapse; Progesterone receptor; Stress urinary incontinence

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; LOWER URINARY TRACT SYMPTOM; MICTURITION DISORDER; MULTIPARA; NOCTURIA; NULLIPARA; OVERACTIVE BLADDER; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS INCONTINENCE; URETHRA PRESSURE; URGE INCONTINENCE; URINARY TRACT BIOPSY; URODYNAMICS;

EID: 80052504903     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-010-1327-6     Document Type: Article

References (29)

1. Irwin DE, Milsom I, Hunskaar S, Reilly K, Koop Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306-1315 (Pubitemid 44692945)
2. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A (2002) Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 186:1160-1166 (Pubitemid 34665053)
3. Abrams P (1994) New words for old: lower urinary tract symptoms for "prostatism". BMJ 308:929-930 (Pubitemid 24111906)
4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardization of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Urology 61:37-49 (Pubitemid 36151708)
5. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293:935-948 (Pubitemid 40271125)
6. Girman CJ, Jacobsen SJ, Tsukamoto T, Richard F, Garraway WM, Sagnier PP, Guess HA, Rhodes T, Boyle P, Lieber MM (1998) Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51:428-436 (Pubitemid 28136681)
7. Iosif CS, Bekassy Z (1984) Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 63 (3):257-260 (Pubitemid 14149172)
8. Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM (2009) Oestrogen therapy for urinary incontinence in postmenopausal women. Cochrane Database Syst Rev. (4):CD001405
9. Blakemen PJ, Hilton P, Bulmer JN (2000) Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU 86:32-38 (Pubitemid 30420760)
10. Skala CE, Petry IB, Albrich SB, Puhl A, Naumann G, Koelbl H (2010) The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients. Eur J Obstet Gynecol Reprod Biol 153 (1):99-103
11. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskow P, Shull BL, Smith AR (1996) The standardization of terminology of female organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10-17 (Pubitemid 26282199)
12. Swift S (2002) Current opinion on the classification and definition of genital tract prolapse. Curr Opin Obstet Gynecol 14(5):503-507 (Pubitemid 36140205)
13. Hengstler JG, Lange J, Kett A, Dornhöfer N, Meinert R, Arand M, Knapstein PG, Becker R, Oesch F, Tanner B (1999) Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Res 59(13):3206-3214 (Pubitemid 29316024)
14. Lang JH, Zhu L, Sun ZJ, Chen J (2003) Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet 80(1):35-39 (Pubitemid 36071339)
15. Ewies AA, Thompson J, Al-Azzawi F (2004) Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data. Hum Reprod 19(7):1622-1628 (Pubitemid 38997193)
16. Battersby S, Robertson BJ, Anderson TJ, King RJ, McPherson K (1992) Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer 65 (4):601-607
17. Chen HY, Chung YW, Lin WY, Chen WC, Tsai FJ, Tsai CH (2009) Progesterone receptor polymorphism is associated with pelvic organ prolapse risk. Acta Obstet Gynecol Scand 88(7):835-838
18. Xie Z, Shi H, Zhou C, Cong M, Hong L, Jin H (2007) Alterations of estrogen receptor alpha and beta in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 134(2):254-258 (Pubitemid 47451599)
19. Bai SW, Chung DJ, Yoon JM, Shin JS, Kim SK, Park KH (2005) Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J 16:492-496 (Pubitemid 41631065)
20. Imamov O, Yakimuchuk K, Morani A, Schwend T, Wada Hiraike O, Rzumov S, Warner M, Gustafsson JA (2007) Estrogen receptor aβ-deficient female mice develop a bladder phenotype resembling human interstitial cystitis. Proc Natl Acad Sci USA 104 (23):9806-9809 (Pubitemid 47179828)
21. Kim JC, Yoo JS, Park EY, Hong SH, Seo SI, Hwang TK (2008) Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction. BJU Int 101(3):371-375
22. Long CY, Hsu CS, Shao PL, Liu CM, Su JH, Tsai EM (2009) Effect of ovariectomy on the gene expression of detrusor muscarinic receptors in female rats. Fertil Steril 92(3):1147-1149
23. Hextall A, Bidmead J, Cardozo L, Hooper R (2001) The impact on the menstrual cycle on urinary symptoms and the results of urodynamic investigation. BJOG 108:1193-1196 (Pubitemid 33052486)
24. Bezwoda WR, Esser JD, Dansey R, Kessel I, Lange M (1991) The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen. Cancer 68:867-872
25. Elledge RM, Green S, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, Martino S, Osborne CK (2000) Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study. Int J Cancer 89:111-117 (Pubitemid 30185917)
26. Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ et al (1992) Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol 10:1284-1291
27. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T (2001) Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97:116-120 (Pubitemid 32057168)
28. Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 83:12-18 (Pubitemid 24027373)
29. Edwall L, Carlström K, Jonasson AF (2009) Different estrogen sensitivity of urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 28 (6):516-520